首页> 美国卫生研究院文献>Redox Biology >Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α
【2h】

Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α

机译:降低人类医学状况中氧化应激生物标志物水平的策略:对8-异前列腺素F2α的荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The widespread detection of elevated oxidative stress levels in many medical conditions has led to numerous efforts to design interventions to reduce its effects. Efforts have been wide-ranging, from dietary changes to administration of antioxidants, supplements, e.g., omega-3-fatty acids, and many medications. However, there is still no systemic assessment of the efficacy of treatments for oxidative stress reduction across a variety of medical conditions.The goal of this meta-analysis is, by combining multiple studies, to quantitate the change in the levels of the popular oxidative stress biomarker 8-iso-prostaglandin F2α (8-iso-PGF2α) after a variety of treatment strategies in human populations.Nearly 350 unique publications with 180 distinct strategies were included in the analysis. For each strategy, the difference between pre- or placebo and post-treatment levels calculated using Hedges’ g value of effect. In general, administration of antibiotics, antihyperlipidemic agents, or changes in lifestyle (g = − 0.63, − 0.54, and 0.56) had the largest effect. Administration of supplements, antioxidants, or changes in diet (g = − 0.09, − 0.28, − 0.12) had small quantitative effects. To fully interpret the effectiveness of these treatments, comparisons to the increase in g value for each medical condition is required. For example, antioxidants in populations with coronary artery disease (CAD) reduce the 8-iso-PGF2α levels by g = − 0.34 ± 0.1, which is quantitatively considered a small effect. However, CAD populations, in comparison to healthy populations, have an increase in 8-iso-PGF2α levels by g = 0.38 ± 0.04; therefore, the overall reduction of 8-iso-PGF2α levels is ≈ 90% by this treatment in this specific medical condition.In conclusion, 8-iso-PGF2α levels can be reduced not only by antioxidants but by many other strategies. Not all strategies are equally effective at reducing 8-iso-PGF2α levels. In addition, the effectiveness of any strategy can be assessed only in relation to the medical condition investigated.
机译:在许多医疗条件下广泛检测到升高的氧化应激水平,导致人们做出了许多努力来设计干预措施以降低其影响。从饮食改变到抗氧化剂,补充剂(例如,ω-3脂肪酸)和许多药物的施用,工作范围广泛。然而,目前尚无系统评估各种医学状况下减轻氧化应激的功效的方法。这项荟萃分析的目的是通过结合多项研究来量化流行的氧化应激水平的变化生物标记物8-异前列腺素F2α(8-异-PGF2α)经过多种治疗策略后在人群中进行了分析。近350种独特出版物包含180种不同策略。对于每种策略,使用Hedges的g效应值计算的治疗前或安慰剂与治疗后水平之间的差异。通常,抗生素,抗高血脂药或生活方式的改变(g =-0.63,-0.54和0.56)的给药效果最大。服用补充剂,抗氧化剂或改变饮食(g = −0.09,−0.28,−0.12)的定量影响很小。为了充分解释这些治疗的有效性,需要将每种医疗状况的g值增加进行比较。例如,冠状动脉疾病(CAD)人群中的抗氧化剂将8-iso-PGF2α水平降低g = reduce- 0.34±0.1,从数量上看这是很小的作用。然而,与健康人群相比,CAD人群的8-iso-PGF2α水平增加了g = 0.38±0.04;因此,在这种特定的医学状况下,通过这种治疗可总体降低8-iso-PGF2α的水平约90%。总之,不仅可以通过抗氧化剂,而且可以通过许多其他策略来降低8-iso-PGF2α的水平。并非所有策略都能有效降低8-iso-PGF2α水平。此外,任何策略的有效性都只能根据所调查的医疗状况进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号